S-3129 : Still Just a Bill

Lower Costs, More Cures Act of 2019

This bill establishes and modifies several requirements to address prescription drug prices under Medicare.

The bill generally

  • limits payment amounts for drugs and biologics under Medicare medical services,
  • reduces cost-sharing under the Medicare prescription drug benefit, and
  • establishes several reporting requirements for drug manufacturers with respect to drug prices.

Action Timeline

Action DateTypeTextSource
2019-12-19IntroReferralRead twice and referred to the Committee on Finance.Senate
2019-12-19IntroReferralIntroduced in SenateLibrary of Congress

Policy Area :

Health
See Subjects
  • Administrative law and regulatory procedures
  • Advisory bodies
  • Business records
  • Civil actions and liability
  • Competitiveness, trade promotion, trade deficits
  • Congressional oversight
  • Consumer affairs
  • Executive agency funding and structure
  • Federal officials
  • Fraud offenses and financial crimes
  • Government employee pay, benefits, personnel management
  • Government information and archives
  • Health care costs and insurance
  • Health care coverage and access
  • Health information and medical records
  • Health personnel
  • Health programs administration and funding
  • Health technology, devices, supplies
  • Income tax deductions
  • Income tax exclusion
  • Inflation and prices
  • Insurance industry and regulation
  • Medicaid
  • Medicare
  • Office of the U.S. Trade Representative
  • Poverty and welfare assistance
  • Prescription drugs
  • Retail and wholesale trades
  • Trade agreements and negotiations
  • Women's health